多层面上气道手术对比内科管理对中重度阻塞性睡眠呼吸暂停患者呼吸暂停低通气指数及日间嗜睡的影响:SAMS随机临床试验
这项多中心、平行组、开放标签随机临床试验纳入102例常规器械治疗失败的中重度阻塞性睡眠呼吸暂停成人,比较多层面上气道手术与持续内科管理。6个月时手术组呼吸暂停低通气指数和Epworth嗜睡量表评分均显著低于内科管理组,组间基线校正差异分别为-17.6事件/小时和-6.7分。
要点
- 常规治疗失败的中重度OSA患者,多层面手术可降低AHI和ESS评分。
- 6个月时AHI组间基线校正差异为-17.6事件/小时,ESS差异为-6.7分。
- 手术组2例(4%)发生严重不良事件,需进一步评估长期疗效与安全性。
核心结论
- 在常规治疗失败的中重度OSA成人中,与内科管理相比,腭部联合舌部手术在6个月时减少了呼吸暂停低通气事件数和患者报告的嗜睡。
- 作者指出这是初步研究,需在更多人群中确认 findings,并了解临床效用、长期疗效和安全性。
研究设计与样本
- 多中心、平行组、开放标签随机临床试验,比较上气道手术与持续内科管理。
- 2014年11月至2017年10月入组,随访至2018年8月。
- 共随机102例有症状的中重度OSA成人,常规治疗失败;手术组51例,内科管理组51例。
- 91例(89%)完成试验;平均(SD)年龄44.6(12.8)岁,女性18例(18%)。
主要发现
- 手术组平均AHI从基线47.9降至6个月20.8;内科管理组从45.3降至34.5。
- 6个月时AHI基线校正组间差异为-17.6事件/小时(95%CI,-26.8至-8.4;P<.001)。
- 手术组平均ESS从基线12.4降至6个月5.3;内科管理组从11.1降至10.5。
- 6个月时ESS基线校正组间差异为-6.7(95%CI,-8.2至-5.2;P<.001)。
- 手术组2例(4%)发生严重不良事件:1例术后第5天心肌梗死,1例因呕陈旧血住院观察。
关键数值与推荐
- 主要结局为AHI(呼吸暂停低通气事件/小时;15-30为中度,>30为重度OSA)和ESS(范围0-24;>10为病理性嗜睡)。
- AHI最小临床重要差异为15事件/小时,ESS为2单位。
- 干预措施:多层面手术(改良悬雍垂腭咽成形术和微创舌体积缩减)或持续内科管理(如睡眠体位建议、减重)。
临床怎么用
- 对于常规器械治疗失败的中重度OSA成人,多层面上气道手术可考虑作为治疗选择之一。
- 临床决策需结合患者个体情况,并充分告知手术相关严重不良事件风险。
局限性
- 作者称其为初步研究,需在更多人群中确认结果。
- 长期疗效、临床效用和安全性尚需进一步研究。
- 开放标签设计可能影响患者报告的嗜睡结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Many adults with obstructive sleep apnea (OSA) use device treatments inadequately and remain untreated. OBJECTIVE: To determine whether combined palatal and tongue surgery to enlarge or stabilize the upper airway is an effective treatment for patients with OSA when conventional device treatment failed. DESIGN, SETTING, AND PARTICIPANTS: Multicenter, parallel-group, open-label randomized clinical trial of upper airway surgery vs ongoing medical management. Adults with symptomatic moderate or severe OSA in whom conventional treatments had failed were enrolled between November 2014 and October 2017, with follow-up until August 2018. INTERVENTIONS: Multilevel surgery (modified uvulopalatopharyngoplasty and minimally invasive tongue volume reduction; n = 51) or ongoing medical management (eg, advice on sleep positioning, weight loss; n = 51). MAIN OUTCOMES AND MEASURES: Primary outcome measures were the apnea-hypopnea index (AHI; ie, the number of apnea and hypopnea events/h; 15-30 indicates moderate and >30 indicates severe OSA) and the Epworth Sleepiness Scale (ESS; range, 0-24; >10 indicates pathological sleepiness). Baseline-adjusted differences between groups at 6 months were assessed. Minimal clinically important differences are 15 events per hour for AHI and 2 units for ESS. RESULTS: Among 102 participants who were randomized (mean [SD] age, 44.6 [12.8] years; 18 [18%] women), 91 (89%) completed the trial. The mean AHI was 47.9 at baseline and 20.8 at 6 months for the surgery group and 45.3 at baseline and 34.5 at 6 months for the medical management group (mean baseline-adjusted between-group difference at 6 mo, -17.6 events/h [95% CI, -26.8 to -8.4]; P < .001). The mean ESS was 12.4 at baseline and 5.3 at 6 months in the surgery group and 11.1 at baseline and 10.5 at 6 months in the medical management group (mean baseline-adjusted between-group difference at 6 mo, -6.7 [95% CI, -8.2 to -5.2]; P < .001). Two participants (4%) in the surgery group had serious adverse events (1 had a myocardial infarction on postoperative day 5 and 1 was hospitalized for observation following hematemesis of old blood). CONCLUSIONS AND RELEVANCE: In this preliminary study of adults with moderate or severe OSA in whom conventional therapy had failed, combined palatal and tongue surgery, compared with medical management, reduced the number of apnea and hypopnea events and patient-reported sleepiness at 6 months. Further research is needed to confirm these findings in additional populations and to understand clinical utility, long-term efficacy, and safety of multilevel upper airway surgery for treatment of patients with OSA. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry: ACTRN12614000338662.
引用
- MacKay S, Carney AS, Catcheside PG, et al. Effect of Multilevel Upper Airway Surgery vs Medical Management on the Apnea-Hypopnea Index and Patient-Reported Daytime Sleepiness Among Patients With Moderate or Severe Obstructive Sleep Apnea: The SAMS Randomized Clinical Trial. JAMA. 2020. PMID: 32886102. doi:10.1001/jama.2020.14265
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。